Your browser doesn't support javascript.
loading
[Allogeneic hematopoietic stem cell transplantations for relapsed and refractory acute lymphoblastic leukemia following inotuzumab ozogamicin treatment].
Morishige, Satoshi; Yamasaki, Yoshitaka; Oya, Shuki; Nakamura, Takayuki; Yamaguchi, Maki; Aoyama, Kazutoshi; Mouri, Fumihiko; Mizushima, Yasuko; Nakashima, Osamu; Nagafuji, Koji.
Afiliación
  • Morishige S; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Yamasaki Y; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Oya S; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Nakamura T; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Yamaguchi M; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Aoyama K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Mouri F; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
  • Mizushima Y; Department of Clinical Laboratory Medicine, Kurume University Hospital.
  • Nakashima O; Department of Clinical Laboratory Medicine, Kurume University Hospital.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine.
Rinsho Ketsueki ; 63(4): 271-276, 2022.
Article en Ja | MEDLINE | ID: mdl-35491216

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Veno-Oclusiva Hepática / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Veno-Oclusiva Hepática / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2022 Tipo del documento: Article